AIM
Advantage Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $143K | Buy |
2,819
+1,800
| +177% | +$91.3K | 0.11% | 180 |
|
|
2019
Q2 | $46K | Hold |
1,019
| – | – | 0.04% | 358 |
|
|
2019
Q1 | $49K | Buy |
1,019
+86
| +9% | +$4.14K | 0.04% | 349 |
|
|
2018
Q4 | $49K | Sell |
933
-4
| -0.4% | -$210 | 0.04% | 345 |
|
|
2018
Q3 | $58K | Sell |
937
-1,460
| -61% | -$90.4K | 0.04% | 363 |
|
|
2018
Q2 | $133K | Sell |
2,397
-13,933
| -85% | -$773K | 0.1% | 178 |
|
|
2018
Q1 | $1.03M | Sell |
16,330
-350
| -2% | -$22.1K | 0.39% | 53 |
|
|
2017
Q4 | $1.02M | Buy |
16,680
+223
| +1% | +$13.7K | 0.32% | 69 |
|
|
2017
Q3 | $1.05M | Sell |
16,457
-35,244
| -68% | -$2.25M | 0.34% | 66 |
|
|
2017
Q2 | $2.88M | Buy |
51,701
+1,601
| +3% | +$89.2K | 1.01% | 26 |
|
|
2017
Q1 | $2.72M | Buy |
50,100
+3,769
| +8% | +$205K | 1.08% | 23 |
|
|
2016
Q4 | $2.71M | Buy |
46,331
+45,641
| +6,615% | +$2.67M | 1% | 29 |
|
|
2016
Q3 | $37K | Buy |
690
+523
| +313% | +$28K | 0.01% | 388 |
|
|
2016
Q2 | $12K | Hold |
167
| – | – | 0.01% | 553 |
|
|
2016
Q1 | $11K | Sell |
167
-160
| -49% | -$10.5K | ﹤0.01% | 542 |
|
|
2015
Q4 | $22K | Buy |
327
+160
| +96% | +$10.8K | 0.01% | 445 |
|
|
2015
Q3 | $10K | Hold |
167
| – | – | 0.01% | 535 |
|
|
2015
Q2 | $11K | Sell |
167
-45
| -21% | -$2.96K | 0.01% | 563 |
|
|
2015
Q1 | $14K | Sell |
212
-25
| -11% | -$1.65K | 0.01% | 525 |
|
|
2014
Q4 | $14K | Buy |
+237
| New | +$14K | 0.01% | 466 |
|